© Reuters. FILE PHOTO: The Moderna COVID-19 vaccine sits on the table at Trinity United Church of Christ in Chicago, Illinois, U.S., February 13, 2021. REUTERS/Kamil Krzaczynski
(Reuters) -Advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Thursday unanimously voted to recommend use of Moderna (NASDAQ:) Inc’s COVID-19 vaccine for children and adolescents aged 6 to 17.
CDC Director Rochelle Walensky is expected to sign off on the recommendations shortly, which would allow the U.S. government to start rolling out the Moderna vaccine for these age groups.
Nearly 60% of those aged 12-17 in the United States have been fully vaccinated so far, while the proportion of vaccinated children aged 5-11 has been significantly lower at nearly 30%.
The U.S. Food and Drug Administration authorized Moderna’s vaccine just last week for the 6-11 age group, along with clearance for use in children between 6 months and 5 years old.
Be the first to comment